Circulation

NOVEMBER 29, 2023

Additional relevant studies, published through November 2022, during the guideline writing process, were also considered by the writing committee and added to the evidence tables, where appropriate.StructureAtrial fibrillation is the most sustained common arrhythmia, and its incidence and prevalence are increasing in the United States and globally.

Atrial Fibrillation 76

Atrial Fibrillation Risk Factors Ablation Arrhythmia 76

DAIC

FEBRUARY 12, 2024

“Therefore, we have made the decision to offer only DX technology for new patients needing a single-chamber ICD, providing equivalent therapies along with additional atrial monitoring data, as recommended by current guidelines.” For more information: [link] References: Thomas G, Choi DY, Doppalapudi H, et al. Technol Health Care.

Technology 64

Technology Atrial Fibrillation Defibrillator Sudden Cardiac Death 64

Dr. Smith's ECG Blog

NOVEMBER 4, 2022

Case submitted and written by Mazen El-Baba MD, with edits from Jesse McLaren and edits/comments by Smith and Grauer A 90-year old with a past medical history of atrial fibrillation, type-2 diabetes, hypertension, dyslipidemia, presented with acute onset chest/epigastric pain, nausea, and vomiting.

Ischemia 52

Ischemia STEMI Stenosis Chest Pain 52

Dr. Smith's ECG Blog

NOVEMBER 19, 2016

myocardial infarction), arrhythmias, valvular pathology, shunts, or outflow obstructions. Smith comment: In a large randomized trial of dopamine vs. norepinephrine (11) for shock which was published after the above-mentioned recommendations, dopamine had more adverse events (especially severe dysrhythmias, and especially atrial fibrillation).

Ischemia 40

Ischemia Cardiogenic Shock Aortic Stenosis 40

Cardiometabolic Health Congress

DECEMBER 7, 2023

The American College of Cardiology (ACC) and the American Heart Association (AHA) recently published new guidelines for the diagnosis and management of patients with atrial fibrillation (AF). link] ACC/AHA Release Updated Atrial Fibrillation Guidelines for 2023. Sources: Joglar, J, Chung, M. J Am Coll Cardiol.

Atrial Fibrillation 111

Atrial Fibrillation Risk Factors Ablation Stroke 111

DAIC

MARCH 5, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech , today announced European CE mark approval of the VARIPULSE Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation ( AF ) using pulsed field ablation (PFA). Atrial Fibrillation.

Ablation 59

Ablation Atrial Fibrillation Atrial Flutter Pulmonary 59

DAIC

DECEMBER 19, 2024

Atrial fibrillation is the most common heart rhythm disorder in adults, affecting more than 5 million people in the U.S., The 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation noted that abstaining from caffeine to prevent heart rhythm disturbances is of no benefit to people with AFib.

AFIB 40

AFIB Research Atrial Fibrillation Heart Rhythm 40